Simposio Internacional de Neurología de Santiago 2026
Lunes 13 de julio de 2026 - Miércoles 15 de julio de 2026
Descripción
El XVIII Simposio Internacional de Neurología de Santiago 2026 (SINS 2026) se llevará a cabo de manera presencial entre los días Lunes 13 a miércoles 15 de julio del presente año, en el Aula Magna de la Universidad de los Andes.
Hemos querido mantener la alta calidad académica de nuestros invitados , los que tocarán distintos tópicos de neurología.
Esperamos volver a contar con vuestra valiosa asistencia .
Certificados: Se entregará certificado de asistencia a quienes hayan asistido al menos a 2 días del curso.
El programa se subirá pronto.
Conferencistas
-Dr. Tahseen Mozaffar, Irvine School of Medicine Neuromuscular
-Dr. Rodrigo Noseda, Harvard University - Cefalea
-Dr. Alexander Lehn, Mater Hospital Brisbane - Trastornos del Movimiento , Trastornos Neurologicos Funcionales
-Dr. Michel Toledano, Mayo Clinic Rochester - Neurohospitalismo
-Dr. Alex Rovira , Hospital Valldhebron - Neuroinmunología
-Dra. Yolanda Blanco, Hospital Clinic - Neuroinmunologia
-Dra. Anasthasia Vishnevetsky, , Harvard University- Neuroinmunologia
-Dra. Clio Rubinos, University of North Carolina at Chapel Hill - Epilepsia
-Dr. Martín Köhrmann, Essen Universität - ACV
-Dr. Peter Schellinger, Johannes Wesling Clinic in Minden - ACV
Comité organizador
- Dr. Andrés de la Cerda
- Dr. Mario Rivera
- Dra. Paloma Becker
- Dr Nicholas Earle
- Dr. Alex Espinoza
- Dra. Sofía González
- Dr. Prudencio Lozano
- Dra. Anna Milan
- Dr. Carlos Navarrete
- Dra. Carolina Pelayo
- Dr. Phillipe Salles
- Dr. Nicolás Rebolledo
- Dr Jorge Villacura
Programa
| Lunes 13 Julio 2026 |
|---|
| 07:45-08:15 | Registration and Badge Pick-up |
| Registration and Badge Pick-up | |
| 08:15-08:30 | Welcome & Opening Remarks by Dr. Ismael Correa, Academic Vice Dean of the Faculty of Medicine, Univ. de los Andes |
| Welcome & Opening Remarks by Dr. Ismael Correa, Academic Vice Dean of the Faculty of Medicine, Univ. de los Andes | |
| 08:30-09:00 | Positive Signs in Functional Movement Disorders: Making the Diagnosis. Dr. Alex Lehn |
| Positive Signs in Functional Movement Disorders: Making the Diagnosis. Dr. Alex Lehn | |
| 09:00-09:30 | The diagnosis has been made, now what? Principles in the treatment of FND patients. Dr. Alex Lehn |
| The diagnosis has been made, now what? Principles in the treatment of FND patients. Dr. Alex Lehn | |
| 09:30-10:00 | Prognosis in FND: Should we be reassured? Dr. Alex Lehn |
| Prognosis in FND: Should we be reassured? Dr. Alex Lehn | |
| 10:00-10:20 | Q&A Session |
| Q&A Session | |
| 10:20–11:00 | Deep Brain Stimulation in the Real World: Indications, Pitfalls and Outcomes. Dr. Alex Lehn. |
| Deep Brain Stimulation in the Real World: Indications, Pitfalls and Outcomes. Dr. Alex Lehn. | |
| 11:00–11:20 | Q&A |
| Q&A | |
| 11:20 – 11:50 | Coffee Break sponsored by Biogen |
| Coffee Break sponsored by Biogen | |
| 11:50-12:50 | Biogen Satellite Symposium |
| Biogen Satellite Symposium | |
| 12:50–13:30 | Neurologic Complications of Cancer Immunotherapies. Dr. Michel Toledano. |
| Neurologic Complications of Cancer Immunotherapies. Dr. Michel Toledano. | |
| 13:30–14:10 | Autoimmune Encephalitis: Diagnosis and Misdiagnosis. Dr. Michel Toledano. |
| Autoimmune Encephalitis: Diagnosis and Misdiagnosis. Dr. Michel Toledano. | |
| 14:10–14:20 | Q&A Session |
| Q&A Session | |
| 14:20–15:00 | AstraZeneca Neurofibromatosis Symposium |
| AstraZeneca Neurofibromatosis Symposium | |
| 15:00–15:35 | Lunch sponsored by CINSAN |
| Lunch sponsored by CINSAN | |
| 15:35–16:15 | Diagnosis and Management of Hospitalized Patients with Inflammatory CNS Demyelinating Disorders. Dr. Michel Toledano. |
| Diagnosis and Management of Hospitalized Patients with Inflammatory CNS Demyelinating Disorders. Dr. Michel Toledano. | |
| 16:15–16:25 | Q&A Session |
| Q&A Session | |
| 16:25–17:10 | Redefining Acute Symptomatic Seizure, Understanding the Etiology and the Importance of Patient-Related Outcomes. Dra. Clio Rubinos. |
| Redefining Acute Symptomatic Seizure, Understanding the Etiology and the Importance of Patient-Related Outcomes. Dra. Clio Rubinos. | |
| 17:10-17:55 | Status Epilepticus (SE): Detecting and Preventing Secondary Brain Injury, Management of Refractory and Superrefractory Status Epileptic Including Immunomodulatory Therapies and Ketamine Use. Dra. Clio Rubinos. |
| Status Epilepticus (SE): Detecting and Preventing Secondary Brain Injury, Management of Refractory and Superrefractory Status Epileptic Including Immunomodulatory Therapies and Ketamine Use. Dra. Clio Rubinos. | |
| 17:55-18:25 | Updated Nomenclature in EEG Spanish Speaking Countries: Accurate Translation and Common Language. Dra. Clio Rubinos. |
| Updated Nomenclature in EEG Spanish Speaking Countries: Accurate Translation and Common Language. Dra. Clio Rubinos. | |
| 18:25-18:35 | Q&A Session |
| Q&A Session |
| Martes 14 Julio 2026 |
|---|
| 08:30-09:00 | Registration |
| Registration | |
| 09:00-09:25 | Update on Radiological Criteria for the Diagnosis of Multiple Sclerosis. Dr. Alex Rovira. |
| Update on Radiological Criteria for the Diagnosis of Multiple Sclerosis. Dr. Alex Rovira. | |
| 09:25-09:50 | Neuroradiological Pearls for the Differential Diagnosis of Optic Nerve Pathologies. Dr. Alex Rovira |
| Neuroradiological Pearls for the Differential Diagnosis of Optic Nerve Pathologies. Dr. Alex Rovira | |
| 09:50-10:00 | Q&A Session |
| Q&A Session | |
| 10:00–11:00 | Merck Satellite Symposium. Aging in Multiple Sclerosis: Evidence in Latin America and Clinical Scenarios. Dra. María Célica Ysrraelit. |
| Merck Satellite Symposium. Aging in Multiple Sclerosis: Evidence in Latin America and Clinical Scenarios. Dra. María Célica Ysrraelit. | |
| 11:00–11:30 | Coffee Break sponsored by Merck |
| Coffee Break sponsored by Merck | |
| 11:30–12:30 | Novartis Satellite Symposium. Early High Efficacy: A Strategy to Impact the Future Disease Burden. Dr. Juan Pablo López. |
| Novartis Satellite Symposium. Early High Efficacy: A Strategy to Impact the Future Disease Burden. Dr. Juan Pablo López. | |
| 12:30–12:50 | CAR-T Cell Therapy in Autoimmune Diseases. Dr. Yolanda Blanco. |
| CAR-T Cell Therapy in Autoimmune Diseases. Dr. Yolanda Blanco. | |
| 12:50–13:00 | Q&A Session |
| Q&A Session | |
| 13:00-14:00 | Roche Satellite Symposium. ORATORIO-HAND: Evidence of Real Functional Impact in Progressive Multiple Sclerosis. Dr. Xavier Montalban |
| Roche Satellite Symposium. ORATORIO-HAND: Evidence of Real Functional Impact in Progressive Multiple Sclerosis. Dr. Xavier Montalban | |
| 14:00–14:40 | Lunch sponsored by Roche |
| Lunch sponsored by Roche | |
| 14:40–15:40 | AstraZeneca Satellite Symposium. Shifting the Treatment Paradigm in NMOSD: From Evidence to Clinical Practice. Dr. Lorna Galleguillos. |
| AstraZeneca Satellite Symposium. Shifting the Treatment Paradigm in NMOSD: From Evidence to Clinical Practice. Dr. Lorna Galleguillos. | |
| 15:40-16:05 | MOGAD: Typical and Atypical Presentations. Dr. Anastasia Vishnevetsky. |
| MOGAD: Typical and Atypical Presentations. Dr. Anastasia Vishnevetsky. | |
| 16:05-16:30 | MOGAD Treatment: When and For How Long? Dr. Anastasia Vishnevetsky. |
| MOGAD Treatment: When and For How Long? Dr. Anastasia Vishnevetsky. | |
| 16:30–16:40 | 16:30–16:40 Q&A Session |
| 16:30–16:40 Q&A Session | |
| 16:40–17:10 | Coffee Break sponsored by CINSAN |
| Coffee Break sponsored by CINSAN | |
| 17:10–17:30 | Emerging immunotherapeutic strategies for Progressive Multifocal Leukoencephalopathy. Dr. Michel Toledano. |
| Emerging immunotherapeutic strategies for Progressive Multifocal Leukoencephalopathy. Dr. Michel Toledano. | |
| 17:30–17:40 | Q&A Session |
| Q&A Session | |
| 17:40–18:25 | Pathophysiology of migraine: from Basic Science to Headache Medicine. Dr. Rodrigo Noseda. |
| Pathophysiology of migraine: from Basic Science to Headache Medicine. Dr. Rodrigo Noseda. | |
| 18:25–19:10 | Migraine Aura and Photophobia: Neurobiological Mechanisms and Clinical Implications. Dr. Rodrigo Noseda. |
| Migraine Aura and Photophobia: Neurobiological Mechanisms and Clinical Implications. Dr. Rodrigo Noseda. | |
| 19:10–19:20 | Q&A Session |
| Q&A Session |
| Miércoles 15 Julio 2026 |
|---|
| 07:30-08:00 | Registration |
| Registration | |
| 08:00-08:20 | Management of Intracranial Atherosclerotic Disease. Dr. Peter Schellinger. |
| Management of Intracranial Atherosclerotic Disease. Dr. Peter Schellinger. | |
| 08:20-08:40 | Antiphospholipid Antibody Syndrome and Stroke. Dr. Peter Schellinger. |
| Antiphospholipid Antibody Syndrome and Stroke. Dr. Peter Schellinger. | |
| 08:40-09:00 | Mechanical Thrombectomy in Large-Core Stroke. Dr. Peter Schellinger. |
| Mechanical Thrombectomy in Large-Core Stroke. Dr. Peter Schellinger. | |
| 09:00-09:30 | Update on Best Medical Management in Stroke Prevention: Diabetes, Lipids, Antithrombotics, and Factor XIa Inhibitors. Dr. Martín Köhrmann. |
| Update on Best Medical Management in Stroke Prevention: Diabetes, Lipids, Antithrombotics, and Factor XIa Inhibitors. Dr. Martín Köhrmann. | |
| 09:30-10:00 | When to Intervene in Intracranial or Extracranial Stenosis: Surgery, Stenting, or Medical Therapy? Dr. Martín Köhrmann. |
| When to Intervene in Intracranial or Extracranial Stenosis: Surgery, Stenting, or Medical Therapy? Dr. Martín Köhrmann. | |
| 10:00-10:30 | Q&A Session |
| Q&A Session | |
| 10:30-11:00 | Coffee break sponsored by PTC |
| Coffee break sponsored by PTC | |
| 11:00-12:00 | PTC Satellite Symposium. Mixed Phenotype in hATTR: From Diagnosis to Multidisciplinary Management |
| PTC Satellite Symposium. Mixed Phenotype in hATTR: From Diagnosis to Multidisciplinary Management | |
| 12:00-12:45 | Small Fiber Neuropathies, more than burning feet and pregabalin. Dr. Tahseen Mozaffar. |
| Small Fiber Neuropathies, more than burning feet and pregabalin. Dr. Tahseen Mozaffar. | |
| 12:45-13:00 | Q&A Session |
| Q&A Session | |
| 13:00-14:00 | Lunch sponsored by AstraZeneca |
| Lunch sponsored by AstraZeneca | |
| 14:00-14:45 | AstraZeneca Satellite Symposium. New Perspectives in Generalized Myasthenia Gravis: Clinical Experience and Contemporary Management. Dr. Florencia Aguirre. |
| AstraZeneca Satellite Symposium. New Perspectives in Generalized Myasthenia Gravis: Clinical Experience and Contemporary Management. Dr. Florencia Aguirre. | |
| 14:45 15:30 | Inclusion body myositis, what is new? Dr. Tahseen Mozaffar. |
| Inclusion body myositis, what is new? Dr. Tahseen Mozaffar. | |
| 15:30-16:15 | Inflammatory Myopathies, update on classification and management. Dr. Tahseen Mozaffar. |
| Inflammatory Myopathies, update on classification and management. Dr. Tahseen Mozaffar. | |
| 16:15-16:30 | Q&A Session |
| Q&A Session | |
| 16:30-16:45 | Closing remarks |
| Closing remarks |
Expositores
Dr. Tahseen Mozaffar
UCI Health
EEUU
Neuromuscular UCI Health.
Dr. Rodrigo Noseda
Chile
Ph.D. Neuroscience University of Clermont-I, France. Postdoctoral Fellow Neuroscience. Beth Israel Deaconess Medical Center, Harvard Medical School Advisor Preclinical Neurology.
Dr. Alex Lehn
Australia
Movement Disorders, Princess Alexandra Hospital and Mater Hospital, Brisbane.
Dr. Martin Köhrmann,
Germany
Neurovascular, University Hospital Essen
Dr. Peter D. Schellinger
Germany
Neurovascular, Johannes Wesling University Hospital Minden.
Dra. Clio Rubinos
EEUU
Epilepsy University of North Carolina (UNC) School of Medicine.
Dr. Michel Toledano
EEUU
Hospital Neurology, Mayo Clinic Rochester
Dra. Yolanda Blanco
España
Hospital Clinic Barcelona
Dr. Alex Rovira
España
Neuroinmunología. Hospital Vall d'Hebron
Ubicación
Aula Magna Universidad de los Andes
Monseñor Álvaro del Portillo 12455, Santiago, Las Condes, Región Metropolitana
Auspiciadores
Organizadores
Inscripciones :
Médicos
Inscripción Temprana Médicos: hasta 30 junio: $60.000
Inscripción Tardía Médicos: (desde 01 Julio): $80.000
Inscripción en Congreso: $100.000
Socios SONEPSYN con cuotas al día: sin costo.
Becados, alumnos, médicos Clínica Dávila, Clínica Santa María , Clínica Vespucio y Clínica Universidad de los Andes: sin costo, solo inscribirse online. Usar código de descuento becados2026
Otros profesionales: sin costo
***La confirmación de la inscripción se hace una vez que se realiza el pago de la inscripción con tarjeta a través de esta página o vía transferencia
Razón Social: Corporación De Investigación De Neurología De Santiago
• Email: andresdelacerda@gmail.com
• Rut: 65.092.002-3
• Giro: Organización sin fines de lucro
• Teléfono: 991580664
• Nombre Contacto: Andrés De La Cerda
• Banco: BICE
• Tipo Cuenta: Cuenta Corriente
• N° Cuenta Bancaria : 14006001